ECHS1 and renal cell carcinoma: Specifically, ECHS1 downregulation inhibits the expression of AMPK-promoted ECHS3 transcriptional activator GATA1, leading to the accumulation of FAs and branched-chain amino acids (BCAAs), thus promoting RCC cell proliferation [107].